Royal Bank of Canada set a €131.00 ($152.33) price objective on Hannover Re (FRA:HNR1) in a research note released on Friday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
HNR1 has been the topic of a number of other research reports. Independent Research set a €85.00 ($98.84) price target on Henkel AG & Co KGaA and gave the stock a sell rating in a research report on Tuesday, May 7th. DZ Bank reissued a neutral rating on shares of Hannover Re in a research report on Monday, June 24th. Societe Generale set a €119.00 ($138.37) price objective on Hannover Re and gave the stock a sell rating in a research note on Wednesday, May 15th. Credit Suisse Group restated a neutral rating and set a $100.00 price objective on shares of Procter & Gamble in a research note on Tuesday, April 23rd. Finally, Barclays restated an underweight rating and set a GBX 600 ($7.84) price objective on shares of in a research note on Monday, July 8th. Five research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. The stock presently has an average rating of Hold and an average target price of €121.66 ($141.46).
HNR1 opened at €142.90 ($166.16) on Friday. Hannover Re has a 12-month low of €94.75 ($110.17) and a 12-month high of €116.37 ($135.31). The stock’s fifty day moving average price is €141.97.
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Featured Story: Why is the ex-dividend date different from the record date?
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.